Systemic IL-6 and Severe Asthma
- PMID: 32687393
- PMCID: PMC7605205
- DOI: 10.1164/rccm.202006-2354LE
Systemic IL-6 and Severe Asthma
Comment in
-
Reply to Nannini and to Lipworth et al.Am J Respir Crit Care Med. 2020 Nov 1;202(9):1325-1326. doi: 10.1164/rccm.202006-2531LE. Am J Respir Crit Care Med. 2020. PMID: 32687407 Free PMC article. No abstract available.
Comment on
-
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency.Am J Respir Crit Care Med. 2020 Oct 1;202(7):973-982. doi: 10.1164/rccm.201909-1813OC. Am J Respir Crit Care Med. 2020. PMID: 32479111 Free PMC article.
References
-
- Suda K, Tsuruta M, Eom J, Or C, Mui T, Jaw JE, et al. Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol. Am J Respir Cell Mol Biol. 2011;45:510–516. - PubMed
-
- Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020;58:155–168. - PMC - PubMed
